Candel Therapeutics Inc. (CADL)
undefined
undefined%
At close: undefined
6.75
-0.74%
After-hours Dec 13, 2024, 07:59 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -37.94M -18.79M -36.12M -17.68M -8.24M
Depreciation & Amortization 960.00K 778.00K 232.00K 91.00K 43.00K
Stock-Based Compensation 3.09M 2.31M 2.96M 2.11M 400.00K
Other Working Capital -570.00K 1.28M -1.54M 1.49M 500.00K
Other Non-Cash Items 169.00K -15.78M 76.00K 32.00K 2.11M
Deferred Income Tax - - 11.51M 4.61M -
Change in Working Capital -525.00K 71.00K -876.00K 1.77M 513.00K
Operating Cash Flow -34.24M -31.42M -22.22M -9.07M -5.18M
Capital Expenditures -457.00K -1.30M -1.83M -1.48M -159.00K
Acquisitions - - - -39.93M -846.00K
Purchase of Investments - - - -6.00K -39.11M
Sales Maturities Of Investments - - - 39.94M 4.37M
Other Investing Acitivies 177.00K - - 39.93M -34.74M
Investing Cash Flow -280.00K -1.30M -1.83M 38.45M -35.74M
Debt Repayment - 19.91M - 460.00K -
Common Stock Repurchased -121.00K - - - -
Dividend Paid - - - - -
Other Financial Acitivies -121.00K 64.00K 465.00K 30.00K 44.48M
Financial Cash Flow -121.00K 19.97M 71.80M 490.00K 21.98M
Net Cash Flow -34.65M -12.74M 47.75M 29.87M -18.94M
Free Cash Flow -34.70M -32.72M -24.05M -10.55M -5.34M